The antipsychotic medication Abilify (aripiprazole) has recently been linked to an increased risk for type 2 diabetes. Abilify was originally approved for adult patients only, but has been increasingly prescribed to children in recent years. Studies have found that these pediatric patients may be at a significantly increased risk of developing diabetes.
Free Confidential Lawsuit Evaluation: If you or a loved one developed type 2 diabetes after taking Abilify (generic: aripiprazole), you should contact our law firm immediately. You may be entitled to compensation by filing a class action suit against the manufacturer and our lawyers can help.
Update: First Trials in Abilify Gambling Litigation to Begin in June
April 23, 2018 – Lawsuits involving allegations of uncontrollable gambling addictions and other compulsive behavior disorders resulting from use of Abilify are scheduled to begin this summer in the U.S. District Court, District of Florida, where all such federal claims have been consolidated into a multidistrict litigation (MDL) for pretrial handling. According to a recent order by U.S. District Judge Casey Rodgers, 3 bellwether trials have been chosen to kick off the proceedings, the first of which is slated to begin on August 6.
Abilify and Type 2 Diabetes
Abilify, an atypical antipsychotic drug approved to treat schizophrenia and other serious psychological disorders, has recently been found to increase the risk of type 2 diabetes in pediatric patients. In August 2013, researchers at Vanderbilt University Medical Center published a study which found that children who were prescribed atypical antipsychotics like Abilify “off-label” for attention, behavioral or mood disorders were 3x more likely to develop type 2 diabetes compared to children who were prescribed medications that were specifically approved to treat the same conditions.
While earlier studies had noted the association between atypical antipsychotic medications and diabetes, the one conducted at Vanderbilt was the first large, well-designed study to look at the risk in children. The researchers pointed out that the use of these types of drugs for non-psychosis-related disorders in the pediatric population now accounts for the majority of prescriptions.
“This is particularly important for high-risk children, for example, those with elevated weight,” said Wayne A. Ray, Ph.D., senior author of the study. “Children should be monitored carefully for metabolic effects predisposing them to diabetes, and use of the drug should be at the lowest possible dose for the shortest possible time.”
Signs and symptoms of type 2 diabetes may include:
- Increased thirst and frequent urination
- Increased hunger
- Blurred vision
- Slow-healing sores or frequent infections
- Areas of darkened skin
Abilify and Compulsive Gambling, Pathological Behavior
Incidences of compulsive gambling and other pathological behaviors including overeating, excessive shopping and hypersexuality have been reported in Abilify users. These side effects are thought to be caused by Abilify’s influence on dopamine and serotonin receptors in the brain. Click here to learn more.
FDA Warns About Impulse-Control Problems with Abilify
May 3, 2016 – The U.S. Food & Drug Administration (FDA) is requiring new warnings to be added to the labeling of Abilify and other aripiprazole-containing antipsychotic medications regarding compulsive or uncontrollable urges to gamble, binge eat, shop and have sex. These urges were reported to have stopped when the medications was discontinued or the dosage was reduced. These impulse-control problems are rare, but they may result in harm to the patient and others if not recognized, according to the FDA.
Why Our Law Firm Is Filing Individual Lawsuits Opposed To a Class Action
In some instances, a class action may offer some advantages, as they aggregate a large number of individualized claims into one representational lawsuit. The aggregation can increase the efficiency of the legal process, lower the costs of litigation and in some cases offer the solution to a common problem wherein small recoveries do not provide the incentive for any individual or law firm to file an individual lawsuit.
However, a class action suit can also be a detriment to many class members, as they are often forced into a blanket “low ball settlement” and higher attorney fees. At Schmidt & Clark, LLP we understand that our clients are suffering emotionally and economically due to loss of wages and/or high medical bills and we plan to maximize each client’s recovery by filing individual Abilify Lawsuits on their behalf.
Do I Have an Abilify Diabetes Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Abilify Lawsuits. We are handling individual litigation nationwide and currently accepting new diabetes cases in all 50 states.
Free Confidential Case Evaluation: Again, if you or a loved one was diagnosed with type 2 diabetes after taking Abilify, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.